"Disease Progression" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The worsening of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis.
| Descriptor ID |
D018450
|
| MeSH Number(s) |
C23.550.291.656
|
| Concept/Terms |
Disease Progression- Disease Progression
- Disease Progressions
- Progression, Disease
- Progressions, Disease
|
Below are MeSH descriptors whose meaning is more general than "Disease Progression".
Below are MeSH descriptors whose meaning is more specific than "Disease Progression".
This graph shows the total number of publications written about "Disease Progression" by people in this website by year, and whether "Disease Progression" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2009 | 0 | 2 | 2 |
| 2010 | 0 | 1 | 1 |
| 2011 | 0 | 5 | 5 |
| 2012 | 0 | 2 | 2 |
| 2013 | 0 | 2 | 2 |
| 2014 | 0 | 2 | 2 |
| 2015 | 0 | 1 | 1 |
| 2016 | 1 | 2 | 3 |
| 2017 | 0 | 2 | 2 |
| 2018 | 2 | 3 | 5 |
| 2019 | 0 | 7 | 7 |
| 2020 | 0 | 9 | 9 |
| 2021 | 0 | 6 | 6 |
| 2022 | 0 | 2 | 2 |
| 2023 | 0 | 4 | 4 |
| 2024 | 0 | 4 | 4 |
| 2025 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Disease Progression" by people in Profiles.
-
Axial Growth and Myopia Progression After Discontinuing Soft Multifocal Contact Lens Wear. JAMA Ophthalmol. 2025 Feb 01; 143(2):155-162.
-
SALL4 mediates SHP2 inhibition in myocardial fibroblasts through the DOT1L/H3K79me2 signaling pathway to promote the progression of myocardial infarction. Sci Rep. 2024 Dec 28; 14(1):30938.
-
Thiostrepton suppresses colorectal cancer progression through reactive oxygen species related endoplasmic reticulum stress. Toxicol Appl Pharmacol. 2025 Feb; 495:117221.
-
Predicting Diagnostic Conversion From Major Depressive Disorder to Bipolar Disorder: An EHR Based Study From Colombia. Bipolar Disord. 2025 Feb; 27(1):47-56.
-
Association between advanced fibrosis and epigenetic age acceleration among individuals with MASLD. J Gastroenterol. 2025 Mar; 60(3):306-314.
-
Atropine, 0.01%, for Myopia Control. JAMA Ophthalmol. 2023 08 01; 141(8):766-767.
-
Long-term neuropsychological outcomes of deep brain stimulation in early-stage Parkinson's disease. Parkinsonism Relat Disord. 2023 Aug; 113:105479.
-
IMI 2023 Digest. Invest Ophthalmol Vis Sci. 2023 05 01; 64(6):7.
-
Delaying the Onset of Nearsightedness. JAMA. 2023 02 14; 329(6):465-466.
-
Compounding of Low-Concentration Atropine for Myopia Control. Eye Contact Lens. 2022 Dec 01; 48(12):489-492.